Background illustration for clinical trials search

Glomerulonephritis Clinical Trials

Browse 76 glomerulonephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: Worcester MA, Valhalla NY, New Bern NC, Catonsville MD,
Sponsor: Akebia Therapeutics

Sex: All

Age: 18+

Code: NCT07268638

Phase 2, Recruiting

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

for
IgA Nephropathy, Lupus Nephritis (LN),
Location: Hollywood FL, Orangeburg SC, Lawrenceville GA
Sponsor: Akebia Therapeutics

Sex: All

Age: 16+

Code: NCT06419205

Phase 2, Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

for
Lupus Nephritis
Location: Orchard Park NY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06711887

Phase 3, Recruiting

Wellness & Workforce Solution for Lupus/Lupus Nephritis

for
Lupus Nephritis
Location: Atlanta GA
Sponsor: Morehouse School of Medicine

Sex: Female

Age: 18+

Code: NCT06217107

Recruiting

US Zamto-cel Autoimmune Diseases

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Milwaukee WI
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06708845

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease

for
Primary Membranous Nephropathy
Location: Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07571746

Phase 2, Recruiting

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

for
Nephritis, Lupus, Lupus Erythematosus, Systemic
Location: Miami FL, Miami Lakes FL, Doral FL, Kissimmee FL,
Sponsor: Viatris Innovation GmbH

Sex: All

Age: 18 - 70+

Code: NCT07201129

Phase 3, Recruiting

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

for
Refractory Lupus Nephritis, Myasthaenia Gravis,
Location: Denver CO
Sponsor: Kyverna Therapeutics

Sex: All

Age: 18+

Code: NCT07403188

Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

for
Primary Immunoglobulin A Nephropathy (IgAN)
Location: Philadelphia PA, Gainesville FL, Aurora CO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 18

Code: NCT06994845

Phase 3, Recruiting

A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis

for
FSGS
Location: New York NY, Chicago IL
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07213960

Phase 2, Phase 3, Recruiting

Safety and Efficacy of ONT01 in Lupus

for
Lupus Nephritis (LN), Lupus Nephritis - WHO Class III,
Location: New York NY
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 18+

Code: NCT07107659

Early Phase 1, Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: New York NY, Miami FL, Winter Park FL, Orlando FL,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase 2, Phase 3, Recruiting

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

for
Primary Membranous Nephropathy
Location: Rochester MN, Minneapolis MN, Houston TX, Loma Linda CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07157787

Phase 2, Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

for
Lupus Nephritis
Location: New York NY, Syracuse NY, Houston TX, San Antonio TX
Sponsor: Autolus Limited

Sex: All

Age: 12 - 65

Code: NCT07053800

Phase 2, Recruiting

A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

for
Primary Membranous Nephropathy
Location: Clifton Park NY, Orlando FL, Atlanta GA,
Sponsor: Climb Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07096843

Phase 2, Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: West Long Branch NJ, Willow Grove PA, Rockville MD,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

Dapagliflozin in Active Lupus Nephritis

for
Lupus Nephritis (LN)
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70

Code: NCT07323524

Phase 4, Recruiting

Study of Ravulizumab in Pediatric Participants With Primary IgAN

for
IgAN, IgAVN, Immunoglobulin A Nephropathy,
Location: Aurora CO
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 2 - 18

Code: NCT07024563

Phase 3, Recruiting

Atacicept in Multiple Glomerular Diseases

for
pMN, IgAN, Nephrotic Syndrome, MCD, FSGS
Location: Brisbane CA
Sponsor: Vera Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06983028

Phase 2, Recruiting

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

for
Primary Membranous Nephropathy
Location: The Bronx NY, Greenville NC, London, Cleveland OH,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT06962800

Phase 3, Recruiting

Glomerulonephritis is inflammation of the glomeruli, the tiny filters inside the kidneys, and it can quietly cause protein and blood in the urine for years before kidney function declines. It includes several different diseases, such as IgA nephropathy, the most common worldwide, and FSGS, which often affects younger adults. For a long time treatment was limited to blood pressure medicines and broad immune suppression. Recent years brought the first targeted treatments for some forms, and many more are now being tested to protect kidney function before damage becomes permanent.